Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Tablet screening could help HIV patients get help for addiction and depression

NCT ID NCT03217058

First seen Nov 01, 2025 · Last updated Jun 20, 2026 · Updated 30 times

Summary

This completed study tested a tablet-based screening system for substance use, depression, and anxiety in over 10,000 HIV-positive adults during routine clinic visits. Patients who screened positive were offered behavioral treatments like motivational interviewing and cognitive behavioral therapy. The goal was to see if this approach could increase screening and treatment rates, ultimately improving HIV care outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Kaiser Permanente Division of Research

    Oakland, California, 94612, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

computerized screening and behavioral interventions (motivational interviewing, cognitive behavioral therapy)

What this could lead to

If successful, this approach could make it easier for HIV clinics to identify and treat substance use, depression, and anxiety, potentially improving overall health outcomes for people living with HIV.

What could go wrong

This is an implementation study, not a test of a new drug or cure. Results may vary by clinic setting, and the screening tools may not work equally well for all patients.

Conditions

The condition(s) this trial relates to.

anxiety disorder Depression HIV infectious disease substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.